We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+21.22%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$726M
AUM Growth
+$57.8M
Cap. Flow
+$110M
Cap. Flow %
15.17%
Top 10 Hldgs %
86.8%
Holding
33
New
5
Increased
6
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$11.6M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$10M
3
FORA
Forian
FORA
+$8.15M
4
IMMP
Immutep
IMMP
+$3.96M
5
CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
+$2.56M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$29.8M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$6.07M
3
AMRN
Amarin Corp
AMRN
+$6.06M
4
SEM
Select Medical
SEM
+$5.25M
5
CAPR icon
Capricor Therapeutics
CAPR
+$3.53M

Sector Composition

Rank Sector Weight
1 Healthcare 97.4%
2 Energy 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$202M 27.86%
2,082,555
-40,716
-2% -$3.3M
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$107M 14.78%
837,109
-253,200
-23% -$29.8M
OPK icon
3
Opko Health
OPK
$1.25B
$51.9M 7.16%
12,819,073
-2,200
-0% -$8.63K
AGEN
4
Agenus
AGEN
$275M
$50.4M 6.94%
467,394
-10,190
-2% -$764K
AWH
5
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$48.6M 6.7%
576,473
– –
PACB icon
6
Pacific Biosciences
PACB
$432M
$48.1M 6.62%
1,374,159
-72,300
-5% -$2.1M
VIR icon
7
Vir Biotechnology
VIR
$1.49B
$33.4M 4.6%
705,486
+255,155
+57% +$11.6M
AXDX
8
DELISTED
Accelerate Diagnostics
AXDX
$30.4M 4.19%
377,612
– –
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$2.48B
$30.4M 4.19%
1,920,733
-446,937
-19% -$6.07M
DMTK
10
DELISTED
DermTech, Inc. Common Stock
DMTK
$27.3M 3.76%
655,877
-57,700
-8% -$2.37M
CDAK
11
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$12.6M 1.73%
678,700
+133,340
+24% +$2.56M
FORA
12
DELISTED
Forian
FORA
$10.9M 1.5%
868,342
+712,902
+459% +$8.15M
XBI icon
13
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$10.3M 1.42%
+76,200
New +$10M
YMAB
14
DELISTED
Y-mAbs Therapeutics
YMAB
$10.2M 1.4%
300,642
-80,000
-21% -$2.57M
ATRS
15
DELISTED
Antares Pharma, Inc.
ATRS
$8.28M 1.14%
1,900,000
– –
CFRX
16
DELISTED
ContraFect Corporation
CFRX
$7.43M 1.02%
21,111
+1,706
+9% +$558K
CAPR icon
17
Capricor Therapeutics
CAPR
$380M
$5.98M 0.82%
1,166,249
-833,215
-42% -$3.53M
XBI icon
18
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$3.9M 0.54%
+825,000
New +$108M
IMMP
19
Immutep
IMMP
$57M
$3.87M 0.53%
+1,000,000
New +$3.96M
MOTS
20
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$3.85M 0.53%
12,325
-167
-1% -$54.4K
SEM
21
DELISTED
Select Medical
SEM
$3.74M 0.52%
164,421
-253,179
-61% -$5.25M
AMRN
22
Amarin Corp
AMRN
$293M
$3.73M 0.51%
42,567
-61,675
-59% -$6.06M
BDSX icon
23
Biodesix
BDSX
$218M
$3.11M 0.43%
11,776
– –
SLNO
24
DELISTED
Soleno Therapeutics
SLNO
$2.43M 0.33%
142,133
– –
BHVN
25
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.82M 0.25%
248,200
+214,600
+639% +$17.4M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Oracle Investment Management held 33 positions worth $726M, up 8.7% from $668M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Oracle Investment Management deployed $110M of net new capital in Q2 2021, opening 5 new positions and adding to 6 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 76,200 shares worth $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 100% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was QuidelOrtho, an estimated $29.8M trimmed.

  • Oracle Investment Management's largest Q2 2021 buy was State Street SPDR S&P Biotech ETF: 76,200 shares worth $10.3M.
  • Oracle Investment Management added most to Vir Biotechnology in Q2 2021, an estimated $11.6M increase.
  • Oracle Investment Management's biggest Q2 2021 reduction was QuidelOrtho, cutting an estimated $29.8M.
  • Oracle Investment Management's ten largest holdings make up 87% of its $726M portfolio in Q2 2021.
  • Oracle Investment Management opened 5 new positions and closed 4 in Q2 2021.
  • Oracle Investment Management's portfolio value rose 8.7% quarter-over-quarter to $726M.

Based on Oracle Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.